Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $2.75 on Monday. Galmed Pharmaceuticals has a 1 year low of $2.23 and a 1 […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $2.75 on Monday. Galmed Pharmaceuticals has a 1 year low of $2.23 and a 1 […]
